Appareil pulmonaire
SAFIR 02 Lung
Evaluation of the Efficacy of High Throughput Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Non-small Cell Lung Cancer (Intergroup Trial UNICANCER UC 0105-1305/ IFCT 1301: SAFIR02_Lung)
Paris
CATHERINE DANIEL
Appareil pulmonaire
ATALK - ML39349
An Open-Label, Multicenter, Single-Arm, Phase II Study to Assess the Efficacy and Safety of Alectinib in Patients With ALK-Rearranged Non-Small Cell Lung Cancer After Disease Progression on Prior ALK Inhibitor Therapy
Paris
NICOLAS GIRARD
Pédiatrie Sarcomes
CombinaiR3
First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years
Paris
VALERIE LAURENCE
Appareil pulmonaire
TET-SEL
A Phase II Study of Selinexor (KPT-330) in Patients With Advanced Thymic Epithelial Tumour (TET) Progressing After Primary Chemotherapy.
Paris
NICOLAS GIRARD
Pédiatrie Tumeurs cérébrales
CDRB436G2201
Phase II Open-label Global Study to Evaluate the Effect of Dabrafenib in Combination With Trametinib in Children and Adolescent Patients With BRAF V600 Mutation Positive Low Grade Glioma (LGG) or Relapsed or Refractory High Grade Glioma (HGG)
Paris
ISABELLE AERTS
Appareil Digestif
SCARCE (C17-02 PRODIGE 60)
A Non-comparative Randomized 2:1 Phase II Study of Docetaxel, Cisplatin, and 5-fluorouracil in Combination or Not With Atezolizumab in Patients With Metastatic or Unresectable Locally Advanced Squamous Cell Anal Carcinoma
Paris
BRUNO BUECHER
Appareil pulmonaire
CheckMate 592 (CA209-592)
Protocol Title: An Exploratory Study of the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Treatment-Naive Stage IV or recurrent Non-Small Cell Lung Cancer (NSCLC).
Paris
NICOLAS GIRARD